Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5644728 | Annales de Dermatologie et de Vénéréologie | 2017 | 5 Pages |
Abstract
In dermatomyositis, anti-MDA5 antibody screening is essential for the prognosis since the disease carries a risk of complication with severe lung disease. Bronchial fibroscopy with bronchoalveolar lavage should be considered at the time of diagnosis. Our two cases suggest the need for early screening for pneumocystis pneumonia in the event of respiratory distress and possibly for prophylactic treatment at the start of immunosuppressant therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
M. Aymonier, S. Abed, T. Boyé, H. Barazzutti, B. Fournier, J.-J. Morand,